Positive context积极背景
Stocks股票 / Health Care / PCVX
Vaxcyte Inc · Health Care
PCVX US listed · USD美股 · 美元
Health Care
Russell 2000罗素2000
Speculative / unprofitable投机／未盈利
$56.21
-$0.69 · -1.21%
52w low52周低 $31.42high高 $64.64
Neutral — no clear edge中性 — 无明显优势
A cycle low is due in roughly ~0–3 trading days — watch for the turn, don't front-run it.周期低点预计在约 ~0–3 个交易日内出现——等待转向，切勿抢跑。
As of 2026-09-27截至 2026-09-27
Company intelligence公司情报
The latest call, in context把最新财报放回历史脉络
A synthesized event record across management commentary and recorded metrics. Read as context; verify exact wording in the transcript before relying.综合管理层表述与记录指标形成事件档案。仅供参考；使用前请在电话会原文中核对准确措辞。
Live company record实时公司记录
JavaScript loads the source-bounded event record here. Open Terminal if the live module does not start.JavaScript 会在此加载受来源约束的事件记录。如实时模块未启动，请打开终端。
Continue with full transcript history继续查看完整电话会历史 ↗Pressure context压力背景
History mode历史模式
Context only仅供参考 · not a signal or recommendation不构成信号或建议
Narrative claims may await line-level citation; verify in the transcript.叙述性内容可能仍待逐行引用，请在电话会原文中核对。
Price chart价格图表
daily · interactive日线 · 可交互
Open in Terminal打开终端 ↗
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。
Open the live chart in Terminal在终端中打开实时图表 ↗
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。
MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动 ↗
Technicals技术面
daily bars日线数据 · 2026-09-27
Momentum (RSI 14)动量（RSI 14）
39
Depressed偏低
vs 50-day average相对50日均线
-3.9% below下方
Below trend跌破趋势
vs 200-day average相对200日均线
+2.5% above上方
Long trend up长期向上
Volatility波动率
3th percentile第3百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源，每晚更新。
Earnings财务业绩
next report下次财报 2026-11-0337
Mixed — beat 0 of last 4 quarters表现不稳 — 近 4 季中 0 季超预期
EPS surprise vs consensus, last quarters每股收益相对预期的超预期幅度（近几个季度） · average平均 -25.9%
Financials财务数据
fiscal years财年
Return on equity股本回报率 -0%
Clean稳健
Capital allocation资本配置
Share count change (1y)股数变化（1年）+4.9%
Debt coming due到期债务
SEC filingsSEC 文件Debt schedule not loaded yet.到期债务尚未加载。
This panel is still catching up to the SEC filings for this listing. Check back soon — nothing is being estimated in its place.本面板仍在同步该证券的 SEC 文件，请稍后再查看；此处不作任何估算替代。
A cash-flow scenario is unavailable until the filing inputs are verified.报告数据核实前，现金流情景暂不可用。
Capital-need coverage is not available for this issuer yet.该发行人的资本需求覆盖信息暂不可用。
Reported facts remain separate from the cash-flow scenario until identity and filing provenance are confirmed.在确认身份与报告来源之前，已披露事实与现金流情景保持分离。
Research context only — reported figures from SEC filings, not a rating, a signal or investment advice.仅供研究参考 — 数据摘自 SEC 文件披露口径，不构成评级、信号或投资建议。
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚
News新闻
1 recent stories — mixed1 篇最新报道，多空参半
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
PCVX weekly MACD crossed downPCVX 周线MACD下穿
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向： -$4.8M net (0 buyers, 5 sellers)-$4.8M 净值（0 买家，5 卖家）
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | As of截至 |
|---|---|---|---|---|
| RA Capital Management | D | Holding持有 | 5.8% | 2026-06-30 |
| Baupost Group (Klarman) | D | exitexit | 0.0% | 2026-06-30 |
Signal history信号历史
engine events引擎事件
UNCONFIRMED TURN → NEARING A LOW未确认转向 → 接近低点
GET READY. Day 41 of a typical 23-44-day cycle — inside the window where lows usually form, and short-term momentum is washed out. No confirmed turn yet准备。典型 23-44 天周期的第 41 天——处于低点通常形成的窗口内，且短期动量已被洗净。尚无确认的转向
Sep 25, 2026
PCVX weekly MACD crossed downPCVX 周线MACD下穿
The weekly MACD histogram turned negative — the slower, less-whippy momentum read.周线MACD柱状图转负 — 更慢、更少来回的动量信号。
Sep 24, 2026
NEARING A LOW → UNCONFIRMED TURN接近低点 → 未确认转向
HIGH-RISK · NIMBLE ONLY高风险 · 仅限灵活操作
Sep 18, 2026
NEARING A HIGH → UNCONFIRMED TURN接近高点 → 未确认转向
HIGH-RISK · NIMBLE ONLY高风险 · 仅限灵活操作
Sep 17, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Sep 17, 2026
PCVX StochRSI turned up from oversoldPCVX StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $60.37.StochRSI重回20上方 — 下行动量趋缓的最早预警。$60.37。
Sep 8, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Sep 4, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Sep 3, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Showing the last 15 of显示最近15条，共 154 signals条信号
Company profile公司档案
Recent news最新动态
The Zacks Analyst Blog Highlights Kodiak Sciences, Celldex Therapeutics, Rapport Therapeutics and Vaxcyte
Zacks Investment Research · 2026-09-23
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Statistics — full detail统计数据 — 完整明细
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | -3.3% | +1.3% |
| 1 Month近1月 | -8.0% | +0.9% |
| 3 Months近3月 | -0.5% | +6.1% |
| 6 Months近6月 | +5.7% | +22.3% |
| Year to date年初至今 | +21.0% | +13.8% |
| 1 Year近1年 | +74.9% | +18.5% |
Trading information交易信息
Volatility rank波动率分位
3th pctile
EPS (trailing)每股收益
$-0.01
Off 52-week high距52周高点
-11.2%
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Financials — full detail财务数据 — 完整明细
Latest fiscal year最近财年
Net income净利润
$-766,628
Operating cash flow经营现金流
$-656M
Total assets总资产
$3.0B
Shareholder equity股东权益
$2.7B
Shares outstanding总股本
0.13B
Returns & growth回报与增长
Return on equity股本回报率
-0.0%
Return on assets资产回报率
-0.0%
Asset growth资产增速
-14.5%
Accounting quality checks会计质量检查
- Earnings quality: accruals near the peer median盈利质量：应计利润接近同业中位
- Capital discipline: investment near the peer median资本纪律：投资力度接近同业中位
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Technicals — full detail技术面 — 完整明细
Indicator readings指标读数
RSI (14-day)RSI（14日）
39
RSI (2-day)RSI（2日）
17
vs 20-day average相对20日均线
-5.3%
vs 50-day average相对50日均线
-3.9%
vs 200-day average相对200日均线
+2.5%
Golden cross (50>200)金叉（50>200）
in effect生效中
MACDMACD
below signal位于信号线下方
Timeframe alignment多周期共振
Daily日线
momentum down动能向下
3-day3日线
momentum down — fresh downturn动能向下——刚刚转弱
Weekly周线
momentum down — fresh downturn动能向下——刚刚转弱
When daily through monthly point the same way, moves carry further.当日线到月线方向一致时，行情往往更有延续性。
Volatility regime波动状态
Range state波幅状态
CoiledCOILED
Days compressed已压缩天数
18
Range width percentile波幅宽度分位
8/100
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Earnings — full detail财务业绩 — 完整明细
Surprise history超预期历史
| Quarter季度 | Reported实际 | Expected预期 | Surprise超预期 |
|---|---|---|---|
| Jun 2026 | $-1.97 | $-1.47 | -34.0% |
| Mar 2026 | $-2.30 | $-1.86 | -23.7% |
| Dec 2025 | $-1.80 | $-1.46 | -23.3% |
| Sep 2025 | $-1.56 | $-1.27 | -22.8% |
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Ownership — full detail持仓 — 完整明细
Tracked funds holding it跟踪基金持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | Position市值 |
|---|---|---|---|---|
| RA Capital Management | D | Holding持有 | 5.8% | $667M |
| Baupost Group (Klarman) | D | Exited清仓 | 0.0% | $46M |
Fund positioning基金持仓概览
Tracked funds in the name持有该股的跟踪基金
2
Buying vs selling买入vs卖出
0 : 1
Quarterly trend季度趋势
{'direction': 'distributing', 'n_quarters': 12, 'holders_first': 3, 'holders_last': 1, 'holders_delta': -2, 'value_change_pct': 40.9, 'from_period': '2023-09-30', 'to_period': '2026-06-30', 'available_on': '2026-08-15', 'available_on_first': '2023-11-15', 'holders_series': [3, 3, 3, 3, 4, 4, 3, 2, 2, 1, 2, 1]}{'direction': 'distributing', 'n_quarters': 12, 'holders_first': 3, 'holders_last': 1, 'holders_delta': -2, 'value_change_pct': 40.9, 'from_period': '2023-09-30', 'to_period': '2026-06-30', 'available_on': '2026-08-15', 'available_on_first': '2023-11-15', 'holders_series': [3, 3, 3, 3, 4, 4, 3, 2, 2, 1, 2, 1]}
Insiders & shorts内部人与空头
Insider net buying (6 months)内部人净买入（6个月）
-$4.8M
Insider buyers vs sellers内部人买家vs卖家
0 : 5
Recent fund flows近期基金流向
SPDR S&P BiotechSPDR S&P Biotech
accumulating持续增持
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。